Pharmigene, Inc. Stock Price

Pharmigene, Inc. designs, develops, manufactures, and sells diagnostic tests in Taiwan and internationally. It offers contract development and manufacturing organization; molecular diagnostic reagents; testing products, including pharmacogenomics, targeted therapy for cancer, disease risk assessment, and functional medicine services. In addition, it sells various platform, such as single-cell analysis platform / spatial gene expression; single-cell and spatial transcriptomics data analysis software; expert in mapping genomic structural variations; whole-genome precision annotation platform; single-cell and spatial transcriptomics data analysis software; precise immune cell identification; automated tissue dissociator; and clinical HLA testing platform. The company was founded in 2005 and is headquartered in Taipei, Taiwan.